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Incomplete and inadequate reporting is an avoidable waste that
reduces the usefulness of research. The CONSORT (Consoli-
dated Standards of Reporting Trials) Statement is an evidence-
based reporting guideline that aims to improve research trans-
parency and reduce waste. In 2008, the CONSORT Group
developed an extension to the original statement that addressed
methodological issues specific to trials of nonpharmacologic
treatments (NPTs), such as surgery, rehabilitation, or psychother-
apy. This article describes an update of that extension and pres-
ents an extension for reporting abstracts of NPT trials. To de-
velop these materials, the authors reviewed pertinent literature
published up to July 2016; surveyed authors of NPT trials; and
conducted a consensus meeting with editors, trialists, and
methodologists.
Changes to the CONSORT Statement extension for NPT trials
include wording modifications to improve readers' understand-
ing and the addition of 3 new items. These items address
whether and how adherence of participants to interventions is
assessed or enhanced, description of attempts to limit bias if
blinding is not possible, and specification of the delay between
randomization and initiation of the intervention. The CONSORT
extension for abstracts of NPT trials includes 2 new items that
were not specified in the original CONSORT Statement for ab-
stracts. The first addresses reporting of eligibility criteria for cen-
ters where the intervention is performed and for care providers.
The second addresses reporting of important changes to the
intervention versus what was planned. Both the updated
CONSORT extension for NPT trials and the CONSORT extension
for NPT trial abstracts should help authors, editors, and peer re-
viewers improve the transparency of NPT trial reports.
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Incomplete reporting is responsible for a great deal ofavoidable waste in research (1, 2). The CONSORT
(Consolidated Standards of Reporting Trials) Statement
(3–5), an evidence-based reporting guideline, was de-
veloped to improve research transparency.
Nonpharmacologic treatments (NPTs), such as sur-
gery, rehabilitation, education, psychotherapy, and de-
vices, represent a wide range of interventions. How-
ever, assessing NPTs raises specific methodological
issues related to the complexity of the intervention, the
influence of care providers, the expertise of the center,
and the difficulties of blinding (6–14). To account for
these issues, the CONSORT Group developed a
CONSORT Statement extension for trials of NPTs
(“CONSORT NPT extension”), which was published in
Annals of Internal Medicine in 2008 (15, 16).
In 2010, the main CONSORT Statement was up-
dated (5, 17). To account for this update and method-
ological developments since publication of the original
NPT extension, we aimed to update the CONSORT NPT
extension and develop a CONSORT extension for re-
porting abstracts of NPT trials (18, 19).
METHODS
We updated the CONSORT NPT extension in 3
steps. First, we reviewed the literature to identify up-to-
date evidence. The search is detailed in Appendix 2
(available at Annals.org). Second, we surveyed corre-
sponding authors of published articles citing the 2008
CONSORT NPT extension. Of the 1525 authors invited
by e-mail, 194 (13%) participated. For each item of the
CONSORT NPT extension, participants were asked to
indicate whether they believed the item should be
modified and, if so, why and how. The results of the
survey are reported in Appendix Tables 1 and 2 (avail-
able at Annals.org). From the literature review and the
survey, we synthesized proposals for changes to each
item. Finally, we organized a 2-day consensus meeting
in May 2014 in Paris, France, with 22 participants (9
editors, 6 trialists, and 7 methodologists). During this
meeting, the survey results and proposals for change
were presented and each item was discussed until con-
sensus was reached. After the meeting, we developed
a draft of the current manuscript, which was sent to all
participants for comments. The updated checklist was
not modified at this stage.
Updating the CONSORT NPT Extension
Main Changes to the CONSORT NPT Extension
The revision of the CONSORT NPT extension
checklist consisted of the deletion of items, the addi-
tion of new items, wording changes, and reformatting.
The numbering and content of items were adjusted to
follow the 2010 CONSORT Statement. Some wording
was changed to improve readers' understanding, such
as the use of “care providers” instead of “those per-
forming the intervention” in item 3.
Items 11a and 11b, related to blinding, were mod-
ified because they were incorporated into the 2010
CONSORT Statement. Three new items were added to
account for the difficulties in replicating NPTs, the fre-
quent lack of blinding, and the risk for a differential
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Table 1. 2017 CONSORT Checklist of Information to Include When Reporting Randomized Trials Assessing NPTs*
Checklist Item Number, by
Section/Topic Item
CONSORT Item Extension for NPT Trials
Title and abstract
1a Identification as a randomized trial in the title –
1b Structured summary of trial design, methods, results, and
conclusions (for specific guidance see CONSORT for
abstracts)
Refer to CONSORT extension for abstracts for NPT trials
Introduction
Background and objectives
2a Scientific background and explanation of rationale –
2b Specific objectives or hypotheses –
Methods
Trial design
3a Description of trial design (such as parallel, factorial)
including allocation ratio
When applicable, how care providers were allocated to each trial
group
3b Important changes to methods after trial commencement
(such as eligibility criteria), with reasons
–
Participants
4a Eligibility criteria for participants When applicable, eligibility criteria for centers and for care
providers
4b Settings and locations where the data were collected –
Interventions†
5 The interventions for each group with sufficient details to
allow replication, including how and when they were
actually administered
Precise details of both the experimental treatment and
comparator
5a Description of the different components of the interventions and,
when applicable, description of the procedure for tailoring the
interventions to individual participants.
5b Details of whether and how the interventions were standardized.
5c Details of whether and how adherence of care providers to the
protocol was assessed or enhanced
5d Details of whether and how adherence of participants to
interventions was assessed or enhanced
Outcomes
6a Completely defined pre-specified primary and secondary
outcome measures, including how and when they were
assessed
–




7a How sample size was determined When applicable, details of whether and how the clustering by
care providers or centers was addressed





8a Method used to generate the random allocation
sequence
–
8b Type of randomization; details of any restriction (such as




9 Mechanism used to implement the random allocation
sequence (such as sequentially numbered containers),
describing any steps taken to conceal the sequence
until interventions were assigned
–
Implementation
10 Who generated the random allocation sequence, who




11a If done, who was blinded after assignment to
interventions (for example, participants, care providers,
those assessing outcomes) and how
If done, who was blinded after assignment to interventions (e.g.,
participants, care providers, those administering
co-interventions, those assessing outcomes) and how
11b If relevant, description of the similarity of interventions
11c If blinding was not possible, description of any attempts to limit
bias
Continued on following page
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Table 1—Continued
Checklist Item Number, by
Section/Topic Item
CONSORT Item Extension for NPT Trials
Statistical methods
12a Statistical methods used to compare groups for primary
and secondary outcomes
When applicable, details of whether and how the clustering by
care providers or centers was addressed
12b Methods for additional analyses, such as subgroup
analyses and adjusted analyses
–
Results
Participant flow (a diagram
is strongly
recommended)
13a For each group, the numbers of participants who were
randomly assigned, received intended treatment, and
were analyzed for the primary outcome
The number of care providers or centers performing the
intervention in each group and the number of patients treated
by each care provider or in each center
13b For each group, losses and exclusions after
randomization, together with reasons
–
13c For each group, the delay between randomization and the
initiation of the intervention
New Details of the experimental treatment and comparator as they
were implemented
Recruitment
14a Dates defining the periods of recruitment and follow-up –
14b Why the trial ended or was stopped –
Baseline data
15 A table showing baseline demographic and clinical
characteristics for each group
When applicable, a description of care providers (case volume,
qualification, expertise, etc.) and centers (volume) in each
group
Numbers analyzed
16 For each group, number of participants (denominator)
included in each analysis and whether the analysis was
by original assigned groups
–
Outcomes and estimation
17a For each primary and secondary outcome, results for
each group, and the estimated effect size and its
precision (such as 95% confidence interval)
–
17b For binary outcomes, presentation of both absolute and
relative effect sizes is recommended
–
Ancillary analyses
18 Results of any other analyses performed, including
subgroup analyses and adjusted analyses,
distinguishing pre-specified from exploratory
–
Harms
19 All important harms or unintended effects in each group




20 Trial limitations, addressing sources of potential bias,
imprecision, and, if relevant, multiplicity of analyses
In addition, take into account the choice of the comparator, lack
of or partial blinding, and unequal expertise of care providers
or centers in each group
Generalizability
21 Generalizability (external validity, applicability) of the trial
findings
Generalizability (external validity) of the trial findings according
to the intervention, comparators, patients, and care providers
and centers involved in the trial
Interpretation
22 Interpretation consistent with results, balancing benefits




23 Registration number and name of trial registry –
Protocol
24 Where the full trial protocol can be accessed, if available –
Funding
25 Sources of funding and other support (such as supply of
drugs), role of funders
–
CONSORT = Consolidated Standards of Reporting Trials; NPT = nonpharmacologic treatment.
* Additions or modifications to the 2010 CONSORT checklist. Modifications of the extension are in boldface.
† These items are consistent with the Template for Intervention Description and Replication (TIDieR) checklist.
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delay between randomization and initiation of the inter-
vention. These items are dedicated to whether and how
adherence of participants to interventions is assessed
or enhanced (item 5d), the description of any attempts
to limit bias if blinding is not possible (item 11c), and
the delay between randomization and initiation of the
intervention (item 13c).
The updated NPT checklist is shown in Table 1,
with examples of adequate reporting in Appendix
Table 3 and Appendix Figures 1 and 2 (available at
Annals.org). The modified participant flow diagram is
presented in the Figure.
Development of the CONSORT Extension for
Reporting Abstracts of NPT Trials
The CONSORT extension for abstracts was pub-
lished in 2008 (18). We added 2 new items to this ex-
tension: one for reporting “eligibility criteria for centers
where the intervention is performed and for care pro-
viders”, and one for “any important changes to the in-
tervention delivered from what was planned” (Table 2).
Appendix Table 4 (available at Annals.org) provides ex-
amples of published abstracts that we modified to ad-
here to the CONSORT extension for abstracts of NPT
trials.
Specific Methodological Issues Considered in the
Update to the CONSORT NPT Extension
Complexity of NPTs. Nonpharmacologic treat-
ments frequently involve multicomponent interventions
delivered by multiple care providers, and each compo-
nent or provider may influence the success of the over-
all intervention (20). Nonpharmacologic treatments are
difficult to describe and standardize, and the “active
ingredients” are sometimes difficult to disentangle (21).
Furthermore, the intervention that is actually adminis-
tered may differ substantially from the one that was
planned.
To account for these issues, the updated
CONSORT NPT extension recommends providing a de-
scription of the components of the intervention and,
when applicable, a description of the procedure for tai-
loring the intervention to individual participants (item
5a) in the methods section. We also recommend de-
scribing whether and how the interventions were stan-
dardized (item 5b), whether and how adherence of
care providers to the protocol was assessed or en-
hanced (item 5c), and whether and how adherence of
participants to interventions was assessed or enhanced
(item 5d).
In the results section, authors should report details
of the experimental treatment and comparator as they
were implemented (new item). In the abstract, authors
should report “any important changes to the interven-
tion delivered from what was planned”.
These items are consistent with the Template for
Intervention Description and Replication (TIDieR) checklist
and guidance (22).
Influence of Center and Care Provider Expertise.
For most NPT trials, the volume of the center provid-
ing the intervention and the expertise of the care pro-
viders can greatly affect estimates of treatment effect.
Interventions that are beneficial in one setting may be
less effective or even harmful in another setting (23).
Furthermore, in NPT trials comparing interventions that
could be performed by the same care provider (for ex-
ample, surgical procedures), different methods for allo-
cating care providers to each group are possible—care
providers can deliver the intervention in both groups or
only 1 group. All of these choices can raise specific
methodological and logistical issues (Appendix Table
5, available at Annals.org).
The updated CONSORT NPT extension recom-
mends reporting how care providers were allocated to
each trial group (item 3a), eligibility criteria for centers
and care providers (item 4a), the number of care pro-
viders or centers performing each intervention and the
number of patients treated by each care provider or in
each center (item 13a), and a description of care pro-
viders (for example, case volume, qualification, and ex-
pertise) and centers (volume) in each group (item 15).
Furthermore, the flow diagram (item 13a) includes
a supplementary box to report the number of care pro-
viders or centers performing the intervention in each
treatment group and the number of patients treated by
each care provider or in each center (Figure). The flow
diagram should report summary statistics, but the de-
tailed description of the number of patients included
and treated in each center and each group could be
reported in an appendix. This information is particularly
important because the interpretation and applicability
of the results vary considerably if, for example, 1 high-
volume surgeon in 1 high-volume center performs 90%
of the interventions or if the interventions are well-
distributed in all centers and among all surgeons. Fi-
nally, authors should discuss the limitations related to
any differing expertise of care providers or centers in
each group (item 20) and the generalizability according
to the care providers and centers involved in the trial
(item 21). In the abstract, we also recommend reporting
eligibility criteria for care providers and centers where
the intervention is performed.
Clustering. In individual randomized controlled tri-
als (RCTs), standard sample size calculations and statis-
tical analyses assume that the outcome for each partic-
ipant is independent. However, this may not be true in
individual NPT RCTs in which the outcomes tend to be
more similar for patients treated by the same care pro-
vider than by other care providers (24). Lack of ac-
counting for this type of clustering by care providers
and centers may lead to an underestimation of the sam-
ple size required and result in imprecision (25–27).
Many analysis methods, such as fixed-, random-, or
mixed-effects models and generalized estimating
equations, are available to account for clustering
(28–30).
The updated CONSORT NPT extension recom-
mends reporting details of whether and how the clus-
tering by care providers or centers was addressed in
the sample size calculation (item 7a) and the statistical
analysis (item 12a).
Difficulties of Blinding. Blinding of patients and
care providers is frequently impossible in trials assess-
ing NPTs and often relies on complex methods when it
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is possible (9, 31). Some of these methods rely on
blinding other care providers who do not perform the
intervention but who will care for the patients after the
intervention. To account for this, item 11a was modified
slightly.
If blinding is not possible in a trial, the updated
CONSORT NPT extension recommends reporting this
information explicitly and providing a description of
any attempts to limit bias, such as collection of data by
an independent researcher (item 11c). Furthermore,
the authors are advised to discuss the limitations re-
lated to the lack of blinding when relevant (item 20).
Delay Between Randomization and Initiation of the
Intervention. For most NPT RCTs, a delay may occur
between randomization and delivery of the intervention
(32). This delay is typically related to logistical issues
owing, for example, to scheduling hospitalizations or
visits with the care provider (33). Such a delay could
lead to crossover, loss to follow-up, or nonadherence
to the intervention if the participant's status changes
between randomization and intervention. The delays
can be unequal between trial groups; for example, a
trial comparing chemonucleolysis and manipulation in
patients with lumbar disc herniation had an average
delay of 3 weeks in one group and 13 weeks in the
other group (34). The updated CONSORT NPT exten-
sion recommends reporting “for each group, the delay
between randomization and initiation of the interven-
tion” (item 13c) in the results section.
Adherence to the Original CONSORT NPT
Extension
Several systematic reviews showed poor adher-
ence to the original CONSORT NPT extension. Only
39% of NPT interventions were adequately described in
NPT trial reports (35). A systematic evaluation of surgi-
cal RCTs showed that only 6% and 4% reported how
clustering was addressed in the sample size calculation
and statistical analysis, respectively (36).
DISCUSSION
The updated CONSORT NPT extension should en-
able authors to increase the transparency of their re-
ports and facilitate an accurate interpretation of trial
results. Improving transparency is particularly impor-
tant in the context of the replication crisis in science
(37).
Despite the publication of the CONSORT State-
ment extension to NPT trials, the completeness of re-
porting of NPT trials remains insufficient (38–40). Space
constraints in published articles has been suggested as
one reason for inadequate reporting of interventions;
however, an online appendix or a link to a Web site that
provides access to videos and manuals can be used to
report this essential information. Open-access reposito-
ries, such as the Open Science Framework (https://osf
.io), should facilitate dissemination of this information.




 (n = …)
Allocated to intervention (n = …)
Received allocated intervention (n = …)
Did not receive allocated intervention 
   (give reasons) (n = …)
Excluded (n = …)
   Did not meet inclusion 
      criteria (n = …)
   Declined to participate 
      (n = …) 
   Other reason (n = …)  
Lost to follow-up (give reasons) (n = …)
Discontinued intervention (give reasons) 
   (n = …)
Analyzed (n = …)


































Care providers (n = …), teams (n = …), and
   centers (n = …) performing the intervention
Number of patients treated  by each care 
   provider, team, and center (median = …
   [IQR, min, max])
Lost to follow-up (give reasons) (n = …) 
Discontinued intervention (give reasons)
   (n = …)
Analyzed (n = …)















Allocated to intervention (n = …)
Received allocated intervention (n = …)
Did not receive allocated intervention 
   (give reasons) (n = …)
Care providers (n = …), teams (n = …),  and
   centers (n = …) performing the intervention
Number of patients treated by each care 
   provider, team, and  center (median = … 
   [IQR, min, max])
An extra box relating to care providers and centers has been added for each intervention group. CONSORT = Consolidated Standards of Reporting
Trials; IQR = interquartile range; max = maximum; min = minimum.
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Several initiatives to improve adherence to guide-
lines have already been implemented (41), most during
the submission and peer review process. More recently,
use of an online writing aid based on the CONSORT
guidelines has shown promising results (42).
The process for developing these guidelines fol-
lowed recommended practices (43). The updated
checklist resulted from a consensus, and some specific
issues that were discussed during the meeting, such as
difficulties in recruiting in NPT RCTs because of strong
investigator and patient preferences, did not lead to
changes in the checklist.
Some of the issues considered in this extension can
be applied more broadly to the reporting of RCTs as-
sessing such pharmacologic treatments as complex
chemotherapy. Finally, the updated checklist is consis-
tent with reporting guidelines that were developed af-
ter publication of the 2008 CONSORT extension for
NPTs, particularly the TIDieR checklist for better report-
ing of interventions (22).
We hope the 2017 update of the CONSORT NPT
extension improves the reporting of RCTs. The guide-
lines are not intended to deter authors from publishing
imperfect trials—the perfect trial being difficult to
achieve—but to ensure transparency and a coherent ap-
proach to testing and reporting trials of complex
interventions.
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APPENDIX 2: LITERATURE SEARCH
We searched for studies evaluating adherence to
the CONSORT NPT extension and methodological de-
velopments that we should consider in the update. We
searched Web of Science (search date, November
2013; update, July 2016) to identify all published arti-
cles citing 1 of the 2 articles on the 2008 CONSORT
NPT extension (15, 16). We also searched MEDLINE via
PubMed for studies evaluating the reporting of trials
assessing NPTs since January 2009 (search date, No-
vember 2013; update, July 2016) by using the follow-
ing search strategy: (Reporting AND CONSORT)[tiab],
with a limitation to articles that had an abstract and
were published in English. Finally, we used a personal
collection of reports on new developments related to
the specific methodological issues when assessing
NPTs (for example, clustering within individual-patient
RCTs or complexity of the intervention) and other rele-
vant reporting guidelines developed since the publica-
tion of the 2008 CONSORT extension for NPTs, such as
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the TIDieR checklist developed to report all types of
interventions (22).
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Appendix Table 1. Characteristics of Corresponding
Authors Surveyed About the CONSORT Statement
Extension for RCTs of NPTs (n = 194)*
Characteristic Value














Mean RCTs participants had been involved in (SD), n 9.6 (30.5)
Mean reports of RCTs published (SD), n 3.8 (7.0)
Mean reports of RCTs evaluating NPTs published (SD), n 2.8 (3.7)
Use of CONSORT extension for NPT trials, % 40
CONSORT = Consolidated Standards of Reporting Trials; NPT = non-
pharmacologic treatment; RCT = randomized controlled trial.
* Response rate was 13% (194 of 1525).
Appendix Table 2. Survey Results
Item Item
Number
Original CONSORT NPT Items Participants Who Agreed to
Retain the ItemWithout
Modification (n  194),%
Trial design 3a How care providers were allocated to each trial group 89
Participants 4a Eligibility criteria for centers and those performing the interventions 88
Interventions 5 Precise details of both the experimental treatment and comparator
5a. Description of the different components of the interventions and,
when applicable, descriptions of the procedure for tailoring the
interventions to individual participants
5b. Details of how the interventions were standardized
5c. Details of how adherence of care providers with the protocol was
assessed or enhanced
72
Sample size 7a Details of whether and how the clustering by care providers or centers was
addressed
89
Blinding 11a Whether or not those administering co-interventions were blinded to
group assignment
81
Statistical methods 12a Details of whether and how the clustering by care providers or centers was
addressed
88
Participant flow 13a The number of care providers or centers performing the intervention in
each group and the number of patients treated by each care provider




New item Details of the experimental treatment and comparator as they were
implemented
81
Baseline data 15 When applicable, a description of care providers (case volume,
qualification, expertise, etc.) and centers (volume) in each group
88
Limitations 20 In addition, take into account the choice of the comparator, lack of or
partial blinding, and unequal expertise of care providers or centers in
each group
89
Generalizability 21 Generalizability (external validity) of the trial findings according to the
intervention, comparators, patients, and care providers and centers
involved in the trial
89
CONSORT = Consolidated Standards of Reporting Trials; NPT = nonpharmacologic treatment.
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Appendix Figure 1. Example of a participant flow diagram for a single-center trial of surgery.
Assessed for eligibility (n = 130)
Excluded (n = 14)
   Declined to participate: 5
   Did not meet inclusion criteria: 9
Randomly assigned (n = 116)
Allocated to standard (single-layer 
anastomosis) (n = 59)
   Received allocated intervention: 59
   Did not receive allocated intervention: 0
Allocated to intervention (double-layer 
anastomosis) (n = 57)
   Received allocated intervention: 57
   Did not receive allocated intervention: 0
Surgeons
   Surgeon 1: 40 patients
   Surgeon 2: 19 patients
Surgeons
   Surgeon 1: 35 patients
   Surgeon 2: 22 patients
Lost to follow-up (n = 0) Lost to follow-up (n = 0)
Analyzed (n = 59) 
Excluded from analysis (n = 0)
Analyzed (n = 57) 
Excluded from analysis (n = 0)
Adapted from reference 87.
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Appendix Figure 2. Example of a participant flow diagram for a multicenter trial of participative interventions.
Assessed for eligibility (n = 509) Excluded (n = 129)
   Did not meet inclusion criteria: 45
   Declined to participate: 44
   Enrolled and consented but not 
      randomly assigned: 4
   Other reason: 36Randomly assigned (n = 380)
Allocated to massage therapy (n = 188)
Unable to obtain baseline assessment (n = 16)
   Died: 2
   Disenrolled prematurely, alive: 11
   Other reason/scheduling: 3
Treatment providers performing the treatment
(n = 23)
Sites (n = 14)
Number of patients treated by each
   Treatment provider (median, 4 [IQR, 2–10]; 
      min, 1; max, 29)
   Site (median, 5 [IQR, 2–17]; min, 1; max, 46)
Unable to provide first treatment (n = 21)
   Died: 3
   Disenrolled prematurely, alive: 13
   Unable/unavailable/declined: 0
   Other: 5
<6 treatments provided (n = 38)
   Died: 13
   Disenrolled prematurely, alive: 10
   Unable/unavailable/declined: 10
   Other: 5
6 treatments provided (n = 113)
Analyzed immediate outcomes 
   (n = 151)*
Excluded from analysis (n = 21)




















































Analyzed sustained outcomes 
   (n = 171)†
Excluded from analysis (n = 1)
   No sustained outcome data: 1
Analyzed immediate outcomes 
   (n = 147)*
Excluded from analysis (n = 30)
   No immediate outcome data: 30
Analyzed sustained outcomes 
   (n = 177)†
Excluded from analysis (n = 0)
Unable to provide first treatment (n = 30)
   Died: 8
   Disenrolled prematurely, alive: 16
   Unable/unavailable/declined: 0
   Other: 6
<6 treatments provided (n = 54)
   Died: 14
   Disenrolled prematurely, alive: 21
   Unable/unavailable/declined: 13
   Other: 6
6 treatments provided (n = 93)
Treatment providers performing the treatment
(n = 33)
Sites (n = 13)
Number of patients treated by each
   Treatment provider (median, 3 [IQR, 1–6]; 
      min, 1; max, 30)
   Site (median, 5 [IQR, 4–17]; min, 2; max, 37)
Allocated to control (n = 192)
Unable to obtain baseline assessment (n = 15)
   Died: 4
   Disenrolled prematurely, alive: 7
   Other reason/scheduling: 4
Assessments refer to the weekly or sustained outcomes. Immediate outcome data collection occurred in conjunction with every treatment session.
IQR = interquartile range; max = maximum; min = minimum. Reproduced from reference 81, with permission.
* Number who had any treatment: 113  38 for massage therapy and 93  54 for control.
† Number with baseline or any sustained outcome assessments: 188  17 for massage therapy and 192  15 for control.
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Appendix Table 4. Examples of Abstracts Adherent to the CONSORT Extension for Abstracts of NPT Trials*
Title and Abstract of a Participative Intervention RCT Adherent to
CONSORT NPT Abstracts
Title and Abstract of Surgical RCT Adherent to CONSORT NPT
Abstracts
Title: Massage therapy versus simple touch to improve pain and mood in
patients with advanced cancer: a randomized trial (81).
Background: Small studies of variable quality suggest that massage
therapy may relieve pain and other symptoms.
Objective: To evaluate the efficacy of massage for decreasing pain and
symptom distress and improving quality of life among persons with
advanced cancer.
Design: 2-arm parallel group single blind multisite, randomized clinical
trial using a centralized computer generated randomization process.
Only data collectors were blinded to treatment assignment
(ClinicalTrials.gov: NCT00065195).
Setting: 15 U.S. hospices of the population-based Palliative Care
Research Network.
Patients: 380 adults with advanced cancer who were experiencing
moderate-to-severe pain (188 massage therapy, 192 control).
Intervention: Six 30-minute massage sessions by licensed therapists with
at least 6 months of experience or simple-touch sessions provided
after a standardized training over 2 weeks.
Measurements: Primary outcomes were immediate (Memorial Pain
Assessment Card, 0- to 10-point scale) and sustained (Brief Pain
Inventory [BPI], 0- to 10-point scale) change in pain over 3 weeks.
Secondary outcomes were immediate change in mood (Memorial Pain
Assessment Card) and 60-second heart and respiratory rates and
sustained change in quality of life (McGill Quality of Life Questionnaire,
0- to 10-point scale), symptom distress (Memorial Symptom
Assessment Scale, 0- to 4-point scale), and analgesic medication use
(parenteral morphine equivalents [mg/d]). Immediate outcomes were
obtained just before and after each treatment session. Sustained
outcomes were obtained at baseline and weekly for 3 Weeks.
Results: 298 (151 massage therapy, 147 control) patients were included
in the immediate outcome analysis and 348 (171 massage therapy,
177control) in the sustained outcome analysis. A total of 82 patients
did not receive any allocated study treatments (37 massage patients,
45 control patients). Both groups demonstrated immediate
improvement in pain (massage, −1.87 points [95% CI, −2.07 to −1.67
points]; control, −0.97 point [CI, −1.18 to −0.76 points]) and mood
(massage, 1.58 points [CI, 1.40 to 1.76 points]; control, 0.97 point [CI,
0.78 to 1.16 points]). Massage was superior for both immediate pain
and mood (mean difference, 0.90 and 0.61 points, respectively; P <
0.001). No between-group mean differences occurred over time in
sustained pain (BPI mean pain, 0.07 point [CI, −0.23 to 0.37 points];
BPI worst pain, −0.14 point [CI, −0.59 to 0.31 points]), quality of life
(McGill Quality of Life Questionnaire overall, 0.08 point [CI, −0.37 to
0.53 points]), symptom distress (Memorial Symptom Assessment Scale
global distress index, −0.002 point [CI, −0.12 to 0.12 points]), or
analgesic medication use (parenteral morphine equivalents, −0.10
mg/d [CI, −0.25 to 0.05 mg/d]). Adverse events were infrequent, were
similar in both groups, and did not seem to be related to treatments.
Limitations: The immediate outcome measures were obtained by
unblinded study therapists, possibly leading to reporting bias and the
overestimation of a beneficial effect. The generalizability to all patients
with advanced cancer is uncertain. The differential beneficial effect of
massage therapy over simple touch is not conclusive without a usual
care control group.
Conclusion: Massage may have immediately beneficial effects on pain
and mood among patients with advanced cancer. Given the lack of
sustained effects and the observed improvements in both study
groups, the potential benefits of attention and simple touch should
also be considered in this patient population.
Funding: National Institutes of Health and National Center for
Complementary and Alternative Medicine (1R01AT01006-01A2),
Mendel/Asarch Lung Cancer Family Foundation Grants Program.
Title: Surgery Versus Nonsurgical Treatment of Lumbar Spinal Stenosis: A
Randomized Trial (74).
Background: Primary care management decisions for patients with
symptomatic lumbar spinal stenosis (LSS) are challenging, and
nonsurgical guidance is limited by lack of evidence.
Objective: To compare surgical decompression with physical therapy
(PT) for LSS and evaluate sex differences.
Design: Multisite 2-arm parallel group randomized, controlled trial.
(ClinicalTrials.gov: NCT00022776). Randomization was computer
generated and concealed using sequentially numbered and sealed
envelopes.
Setting: Neurologic and orthopedic surgery departments and PT clinics.
Participants: Surgical candidates with LSS aged 50 years or older who
consented to surgery.
Intervention: Surgical decompression or PT. All surgical procedures were
performed by fellowship-trained spine surgeons or surgeons with
more than 20 years of experience dedicated to spine surgery. Physical
therapy was prescribed for 6 weeks, with a frequency of 2 visits per
week, and was delivered by licensed physical therapists.
Measurements: Primary outcome was physical function score on the
Short Form-36 Health Survey at 2 years assessed by masked testers.
Results: The study took place from November 2000 to September 2007.
A total of 169 participants were randomly assigned and stratified by
surgeon and sex (87 to surgery and 82 to PT), with 24-month follow-up
completed by 74 and 73 participants in the surgery and PT groups,
respectively.
All but 2 patients assigned to the surgery group received surgery. In
contrast, 47 (57%) of the participants in the PT group crossed over to
surgery over the 2-year period.Mean improvement in physical function
for the surgery and PT groups was 22.4 (95% CI, 16.9 to 27.9) and 19.2
(CI, 13.6 to 24.8), respectively. Intention-to-treat analyses revealed no
difference between groups (24-month difference, 0.9 [CI, −7.9 to 9.6]).
Sensitivity analyses using causal-effects methods to account for the
high proportion of crossovers from PT to surgery (57%) showed no
significant differences in physical function between groups.
Thirty-three surgery-related complications occurred, 11 of which were
in participants who crossed over from PT to surgery. All 9 PT-related
complications were reports of worsening symptoms.
Limitation: Without a control group, it is not possible to judge success
attributable to either intervention.
Conclusion: Surgical decompression yielded similar effects to a PT
regimen among patients with LSS who were surgical candidates.
Patients and health care providers should engage in shared
decision-making conversations that include full disclosure of evidence
involving surgical and nonsurgical treatments for LSS.
Primary Funding Source: National Institutes of Health and National
Institute of Arthritis and Musculoskeletal and Skin Diseases.
CONSORT = Consolidated Standards of Reporting Trials; NPT = nonpharmacologic treatment; RCT = randomized controlled trial.
* Original abstracts were modified to adhere to the CONSORT extension for abstracts and the CONSORT extension for abstracts of NPT trials
(CONSORT NPT abstracts). Information requested for CONSORT NPT abstracts is in boldface.
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Appendix Table 5. Allocation of Care Providers to Each
Trial Group
Allocation Across Group
In NPT trials where care providers could perform the intervention in both
groups, the allocation of care providers to each trial group raises
specific issues. Several situations are possible, all having
advantages and drawbacks.
Care providers deliver the intervention in both groups.
In this situation, care providers may have to administer an intervention
they are less confident with or expert in. Consequently, there is a
risk for:
Low adherence to the protocol
Contamination (i.e., participants randomly assigned in 1 group
inadvertently receive the intervention [or some component
of the intervention] that is allocated to the other group) (82).
Contamination may underestimate treatment effect estimates
and reduce the study power.
Differential expertise bias (i.e., a disproportionate number of patients
treated by an expert care provider in 1 group compared with the
other group).
Care providers could be randomly assigned to perform the
intervention in 1 group.
Care providers may be randomly assigned to an intervention they are
not expert in or are less committed to. This situation would
increase the risk for low adherence and contamination.
Care providers could perform only the intervention they prefer or are
expert in. Such choice is also called an “expertise-based
randomized controlled trial” (83, 84). This design has several
advantages. It should reduce the risk for contamination, take into
account the learning curve and avoid the risk for differential
expertise bias, and facilitate participation of care providers and
patients. However, it also raises feasibility issues and questions the
applicability of the trial results (85, 86).
Allocation Within Group
In some NPT trials, the care providers can perform the intervention in
only 1 group (e.g., surgery vs. drug or surgery vs. physiotherapy).
The allocation of care providers within groups is frequently
determined by logistical considerations. However, in some
situations, care providers could be randomly assigned among a
pool of eligible care providers.
NPT = nonpharmacologic treatment.
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